...  Study Of 3 Biotechs – A Story Of Hope, Potential And Partnerships Athersys has a trial for MultiStem for use in patients suffering from ischemic stroke and also a trail going with Pfizer (PFE) for patients suffering from ulcerative colitis. Both are in Stage II clinical studies. Athersys has also submitted plans to … Read more on Seeking Alpha The Stem Cell Revolution Can Jump-Start Your Portfolio: Jason Kolbert In addition to heart disease, Mesoblast is pursuing degenerative disc disease (DDD) and spinal fusion, both local indications, and systemically, type 2 diabetes and rheumatoid arthritis, all with its mesenchymal precursor cells (MPCs). Athersys is … Read more on Trefis Read ...